Detection of cardiac amyloidosis with
Adult
Aged
Amyloidosis
/ blood
Aniline Compounds
Biomarkers
/ blood
Echocardiography
Female
Heart
/ diagnostic imaging
Heart Failure
/ blood
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Positron Emission Tomography Computed Tomography
Radionuclide Imaging
Stilbenes
Treatment Outcome
Young Adult
Amyloid imaging
Diagnosis
Heart
Response assessment
Retention index
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
07
12
2018
accepted:
08
02
2019
pubmed:
25
2
2019
medline:
15
7
2020
entrez:
25
2
2019
Statut:
ppublish
Résumé
Cardiac amyloidosis (CA) is a rare cause of heart failure with frequently delayed diagnosis, because specific early signs or symptoms are missing. Recently, direct amyloid imaging using positron emission tomography/computed tomography (PET/CT) has emerged. The aim of this study was to examine the performance of Twenty-two patients with proven (n = 5) or clinical suspicion (n = 17) of CA underwent PET demonstrated myocardial Imaging of cardiac amyloidosis (CA) with
Identifiants
pubmed: 30798427
doi: 10.1007/s00259-019-04290-y
pii: 10.1007/s00259-019-04290-y
doi:
Substances chimiques
Aniline Compounds
0
Biomarkers
0
Stilbenes
0
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
TLA7312TOI
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1407-1416Commentaires et corrections
Type : CommentIn
Références
N Engl J Med. 2003 Aug 7;349(6):583-96
pubmed: 12904524
Am J Hematol. 2005 Aug;79(4):319-28
pubmed: 16044444
J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84
pubmed: 16168294
Clin Lymphoma Myeloma. 2005 Nov;6(3):208-19
pubmed: 16354326
Am J Hematol. 2007 Apr;82(4):328
pubmed: 16947323
Am J Cardiol. 2009 Feb 15;103(4):544-9
pubmed: 19195518
JACC Cardiovasc Imaging. 2009 Dec;2(12):1369-77
pubmed: 20083070
JACC Cardiovasc Imaging. 2010 Feb;3(2):155-64
pubmed: 20159642
Amyloid. 2011 Jun;18 Suppl 1:80-2
pubmed: 21838441
Circulation. 2011 Aug 30;124(9):1079-85
pubmed: 21875922
J Nucl Med. 2011 Dec;52 Suppl 2:93S-100S
pubmed: 22144561
J Clin Oncol. 2012 Mar 20;30(9):989-95
pubmed: 22331953
Amyloid. 2012 Jun;19(2):94-8
pubmed: 22587492
J Cardiovasc Magn Reson. 2012 May 20;14:31
pubmed: 22607376
Heart. 2012 Oct;98(19):1442-8
pubmed: 22865865
J Nucl Med. 2013 Feb;54(2):213-20
pubmed: 23238792
J Cardiovasc Magn Reson. 2013 May 01;15:35
pubmed: 23634753
Circ Cardiovasc Imaging. 2013 Nov;6(6):1066-72
pubmed: 24100046
Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1652-62
pubmed: 24841414
Circ Cardiovasc Imaging. 2014 May;7(3):552-62
pubmed: 24847009
Blood. 2015 Apr 2;125(14):2239-44
pubmed: 25636337
Adv Ther. 2015 Oct;32(10):920-8
pubmed: 26498944
Blood. 2016 Jul 14;128(2):159-68
pubmed: 27053535
Circulation. 2016 Jun 14;133(24):2404-12
pubmed: 27143678
J Nucl Med. 2016 Nov;57(11):1733-1739
pubmed: 27307344
J Am Coll Cardiol. 2016 Sep 6;68(10):1014-20
pubmed: 27585505
J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89
pubmed: 27899132
Rofo. 2017 Mar;189(3):204-217
pubmed: 28201839
Pharmacol Ther. 2017 Dec;180:129-138
pubmed: 28648829
N Engl J Med. 1997 Sep 25;337(13):898-909
pubmed: 9302305